A description of the first Candida auris-colonized individuals in New York State, 2016-2017
- PMID: 34793894
- PMCID: PMC9853438
- DOI: 10.1016/j.ajic.2021.10.037
A description of the first Candida auris-colonized individuals in New York State, 2016-2017
Abstract
Candida auris (C. auris) is a globally emerging multidrug-resistant yeast. New York State (NYS) first detected C. auris in July 2016 and is the state most affected. This brief report describes characteristics of the first 114 individuals colonized with C. auris identified through active surveillance/screening by NYS Department of Health. "Colonized/screened" individuals were old (median age, 74 year), had extensive health care exposures and underlying conditions (multiple health care facility admissions in the 90 days prior with more than 80% requiring mechanical ventilation), and had 30- and 90-day mortality rates of 17.5% and 37.7%, respectively (with approximately 60% expired in the 2-year follow-up period). This description is helpful to inform additional prevention measures and add to the collective understanding of C. auris in the United States.
Keywords: Candida auris; colonization; patient and resident characteristics.
Published by Elsevier Inc.
Conflict of interest statement
Conflicts of interest: None to report
References
-
- Centers for Disease Control and Prevention. Candida auris info for laboratories and health professionals [cited 2021 July 26]. Accessed June 12, 2021. https://www.cdc.gov/fungal/candida-auris/health-professionals.html.
-
- New York State Department of Health. Get the facts about Candida auris [cited 2021 October 24, 2021]. Accessed June 12, 2021. https://www.health.ny.gov/diseases/communicable/c_auris/.
-
- Southwick KL, Adams E, Greenko J, et al. New York State 2016–2018: Progression from Candida auris Colonization to Bloodstream Infection. San Francisco: Poster at IDWeek; 2018.
